Investing.com -- Tesla’s sky-high market valuation remains difficult to justify and may become even harder to defend in the near term, according to Morgan Stanley analysts. “Nearly 15 years after going public, investors struggle to justify the value of Tesla (NASDAQ:TSLA) as much as ever before,” the analysts wrote in a note to clients on Monday. Advertisement: High Yield Savings Offers Earn 4.10% APY** on balances of $5,000 or more View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. “We expect this valuation ‘problem’ gets worse before it gets better,” they added. Morgan Stanley pointed out that most investors value Tesla’s core auto business at just $50 to $100 per share—far below its current stock price. “Then they put their pens down. Excel spreadsheet closed,” the firm said. “Stopping here is akin to valuing Amazon (NASDAQ:AMZN) solely as an online retailer or Apple (NASDAQ:AAPL) as a seller of glowing rectangles and earbuds.” The firm highlights Tesla’s potential in several areas beyond cars, including autonomy, energy storage, and humanoid robots. Morgan Stanley estimates that each $100 in monthly revenue per vehicle could be worth $80 to $100 per share. They believe Tesla’s installed base of vehicles could reach 50 million units by the mid-2030s. Energy storage is described as the company’s “fastest growing and highest margin hardware business,” with an estimated value of $67 per share, excluding future recurring revenue potential. Still, analysts caution that Tesla’s valuation largely hinges on “businesses that have either poor disclosure, no disclosure, or that have yet to be launched into the commercial market.” They argue this model poses challenges for public investors more accustomed to valuing proven earnings and cash flow. “Our $800 bull case for the stock would require, in our opinion, at least $20 of EPS,” they said. Tesla currently earns closer to $2 per share. “Ultimately, investors will need to see earnings and cash flow.” Related articles Tesla valuation problem ’to get worse before it gets better’: Morgan Stanley Bath & Body Works shares fall: Appoints new CEO, pre-announces Q1 results Evercore adds Home Depot to Tactical Outperform list ahead of earnings View Comments
Tesla valuation problem ’to get worse before it gets better’: Morgan Stanley
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...